More information from BBNS:
Subject:
WUCEH Special Weekend Report - NVID
Date:
Sun, 08 Sep 1996 14:30:09 +0700
From:
"Bacon B Delivers...." <grizz@wsnet.com>
To:
IN:
To continue the NVID series this weekend, Raleigh addresses more
information from David....
After reading this, I am a grinner!!
Kerry
From: Raleigh Baughman <phantom@imperium.net>
Subject: WUCEH Special Weekend Report - NVID
Content-Length: 25678
Phantom’s WUCEH ™ (Wake Up Call E-mail Hotlist)
September 8, 1996
Special Weekend Report - NVID
In a ongoing dialogue with Dave K (our rogue reporter) comes this excerpt.
Dave writes:
A quick double could be in the works, but the probable increase in the
already good volume should attract some shorters.
Any idea how many may be out there now?
Based on conversation with Bunte, I do not anticipate that the referred to news releases for this month will be earth shaking but will, or at least should, add substance in re; company stability, as especially will the appointment of a creditable outside board. If that does indeed materialize it will, for me at least, represent a major, major step toward establishing NVID as a co. that means business, as it of course means relinquishing of the heretofore tight inside control. He has twice said that announcement would come in October and that the people are significant persons and that they have all accepted the invitation. They are not local cronies.
My reply:
Dave,
I concur with your statement regarding an appointment of an outside board, most encouraging.
I also feel that it will be well received, especially as we are about to see a succession of news releases that will lead us closer to a company that goes from developmental stage, to production stage.
As you can imagine, over the years I have followed several of these
developmental companies and have watched many come to fruition.
In reflecting on what made the difference between success and failure, it almost always could be attributed to one key element; the strength of management.
Management that were honest and stayed focused on there objectives, seemed to always come through and bare fruit. I remember watching TEAM go from .04 EPS losses, to .03, .02, etc., and I stuck with it, not because I just believed they enjoyed a niche in a growing market, but because the management kept their noses to the grindstone and just kept slugging away, constantly broadening their services and client base. Today, TEAM has a broad base of clients, has gone international, and are about to print their first double digit EPS. IDX (Identix) was another that is more easily compared to NVID. They had new technologies, an unlimited market, and management that was focused. Comverse Technologies, Michael Stores, US Homes, Storage Tech, Ion Laser Tech, all enjoyed success because of a dedicated management.
To see NVID seek out a board of directors, and start to focus on taking the company from developmental stage, to production stage, is very encouraging and reinforces my conviction that the timing for investment couldn't be better. As it begins to ramp up the first stage towards Microsafe becoming a revenue generating product for the company, this offers the best chance for
major percentage appreciation.
David, in closing, I just wanted to thank you for your time and energy in giving us your first hand opinion, and to also tell you that I agree fully with your assessment that NVID is about to double in price.
As we continue forward with our quest for all the answers, I assembled the attached list of what I feel are important issues and a brief summation of where we stand thus far. Also attached is a chronological list of recent events.
Hope to hear more from you real soon,
Sincerely,
Raleigh
My quest by priority in evaluating NVID in ascending order is this.
1. Management Team
2. Product viability.
3. Market size for product.
4. Marketing plan.
5. Financial backing to afford implementation of Mktg. Plan.
Thus far, I believe we have started to gather enough information to start putting together a summary conclusion that address some of the above issues.
Particularly # 3. The market size is enormous for Microsafe. In fact I don't feel we have even scratched the surface. I break down the markets into two distinct categories, general disinfectants, and consumable disinfectants.
Both of which are endless in scope of market applications.
What we haven't even made clear is the outside possibility that Microsafe could be classified as a sterilization agent, which far exceeds the category of disinfectant. The difference is significant, and by definition, disinfectant means that it kills some of the germs or bacteria present,sterilization on the other hand means that it literally sterilizes by killing all bacteria present. The company has already gone on record as stating that it kills Staph A, Salmonella C, and Psuedomas A, within 30 seconds of contact. They are also on record as stating that they are about to test against other bacteria and viruses such as Tuberculosis, E. Coli, Polio, Herpes, Influenza, and many others.
If it should prove effective in killing even more of these viruses, it could have wide acceptance in the medical markets as evidenced by the news release on 8/20/96 referring to application in a Veterinarian application. (see attached) Then on 8/22/96 the news release regarding use of Microsafe as a sterilization agent of Endoscopes (attached), just reinforces this optimistic observation.
Would if we took it one step further and it was proven effective in not only prevention, but also cure, of some the listed viruses that cause infections.
Now that's a sobering aspect of a highly speculative nature.
But, would if?
Earlier I mentioned that we haven't scratched the surface, regarding
Microsafe's potential. With that in mind, I like to be more realistic and lets just assume it exceeds or equals the effectiveness of Isopropyl Alcohol, Lysol, or any other widely used general disinfectant. What's that worth? And. if it is proven to be safe for human consumption, then just keep adding sets of three zeroes behind the estimated market potential.
So I think # 3 is why we are most interested.
#5 Financial backing to bring products to market.
I was glad to see that they are sitting on cash and no debt. I would dig deeper as to what that cash position is, but wouldn't put to much emphasis on it. That's why it shows up last on my list. Reason is, if Microsafe lives up to it's expected potential, large companies will beat a path to their door, and license the formulation. If NVID is smart and keeps a close reign on each license's breadth of scope regarding application, they could end up with numerous cash generating agreements. Here again the company is already
on record as stating that two Fortune 500 companies have expressed interest.
That leaves further diligence needed on #1. Management, 2. Product
viability, and 3. Marketing plan.
As for management, although we have some background, only time will tell as to how wisely they perform in both a good business climate and if things should get tough. That is why I welcome the appointment of a good board of directors, we can only wait to assess their credentials. My biggest concern with companies that have this type of explosive growth potential is management's ability to handle rapid expansion. That is usually the downfall of many a young company. The management is good in bringing new technologies, but is lousy in handling the administrative duties that come with rapid expansion. This we will have to be patient and keep a close ongoing evaluation process in place.
2. Product viability is of course undergoing, or about to undergo, more intense testing . I am told that outside laboratory testing is being conducted, as we read this. I was also told that independent testing by very credible laboratories are lined up for more than just general feasibility. This aspect just accents the speculative nature of this investment, but by the same token, it is why we want to be positioned before the results. Once they are known, it will be decisive, either you will have a proverbial gold mine, or you will have wallpaper, so little old ladies with cardiac
problems, need not apply.
4. Marketing plan. Although premature, this will be critical in their bid for success. I will be very interested in how they will structure their deals, what they plan, if any, to hold back for possible self production. Most importantly, is to whom their partners will be. If they have what they claim to have, it will be evident by whom they choose to get into bed with.
Here is a list of current chronological news releases from August on. I think this tells the natural progression, and sets the stage for what we are about to see unfold.
>(NVID-INTERNATIONAL)(NVID) NVID introduces Microsafe and is
>currently negotiating for its worldwide marketing with two Fortune
>500 companies
>
> Business Editors
>
> SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 7, 1996--NVID
>International Inc. (OTC BB:NVID) introduced Microsafe(r), naming
>their revolutionary non-toxic liquid disinfectant.
> While USDA testing and evaluation for non consumable uses in the
>food processing industry will begin within 30 days, the company is
>moving forward to market Microsafe(r) in non-consumable applications.
>Negotiations are ongoing with two major companies for the rights to
>market Microsafe(r) both nationally and internationally.
> Microsafe(r) has shown to be effective in killing 99.999% of
>Staph A, Salmonella C, and Pseudomas A within 30 seconds of contact.
>Its effectiveness and safety has made it ideal for use in hospitals,
>public facilities, pool and spa disinfection and in cleaning
>compounds such as soaps and cleansers.
> In addition, President Bob Bunte stated, "We are extremely
>pleased with the preliminary results of side by side testing against
>Lysol and look forward to additional testing and applications." The
>next testing will be to confirm its effectiveness and kill ratios
>against:
> 1) Tuberculosis (T.B.) 2) E. Coli 0157
> 3) Rhinovirus 4) Rotavirus WA
> 5) Influenza Type AZ 6) Adenovirus, Type 2
> 7) Polio Virus - Type 1 8) Herpes Simplex Virus, Type 1&2
>
> President Bob Bunte also stated: "We see the current share price
>as extremely undervalued in light of the strong sales of Aqua Bio
>Controls, and the substantial potential of Microsafe(r). As we
>continue to progress, I firmly believe that long term shareholders
>will be greatly rewarded."
> NVID International Inc. is a developmental holding company. Its
>wholly owned subsidiary is Aqua Bio Technologies Inc., a marketing
>and distribution company for Electronic Ionization Water Disinfecting
>Equipment with customers in the industrial/commercial,
>hospital/medical and residential pools, spas and fountains.
> For more information, call Robert F. Bunte - 800/226-3415,
>fax 941/922-2535.
> --30--jd/mi*
>
> CONTACT: NVID International Inc., Sarasota
> Robert F. Bunte, 800/226-3415
> 941/922-2535 (fax)
>
>*************************
>
>(NVID-INTERNATIONAL)(NVID) NVID announces Aqua BioControls
>meets stringent standards set by National Sanitation Foundation
>(NSF); can now expand new product line into commercial marketplace
>
> Business Editors
>
> SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 8, 1996--NVID
>International Inc. (OTC BB:NVID) announced Thursday that in
>independent testing, their new electronic ionization product line,
>Aqua BioControl has met or exceeded the standards set forth by the
>National Sanitation Foundation, and ANSI/UL for electrical safety.
> President Bob Bunte stated: "We believe that we are one of only
>four companies in our industry to meet or exceed NSF and ANSI/UL
>standards for sanitation and electrical safety, which places us in
>the enviable envious and advantageous position of being able to
>penetrate the commercial market with the new state of the art line of
>products." Bunte added, "We anticipate worldwide sales of our
>products to continue to escalate to record levels."
> This new product line, Aqua BioControls, is a computerized,
>electronic ionization/water disinfection system which automatically
>monitors and adjusts the ionization process for such variables as a
>pH and chlorine feeding system in pools, spas, fountains, cooling
>towers, marine habitats, hospitals, etc.
> "NVID's potential should not be overlooked or underestimated,"
>noted Bunte, "taking into account the huge and ever increasing
>demand for our new electronic ionization system coupled with our
>non-toxic, liquid disinfectant (Microsafe(r)). NVID will be a leader
>in the critical fight against many forms of bacteria and infectious
>diseases which threaten the masses."
> NVID International Inc. is a developmental holding company. Its
>wholly owned subsidiary is Aqua Bio Technologies Inc., a company
>which develops, manufactures, markets and distributes Electronic
>Water Disinfection Equipment with customers in the
>industrial/commercial, hospital/medical and residential pools, spas,
>and fountains.
>
> --30--pp/mi*
>
> CONTACT: NVID International Inc., Sarasota
> Robert F. Bunte
> 800/226-3415, fax 941/922-2535
>
>********************************
>
>
>(NVID-INTERNATIONAL)(NVID) NVID International enters veterinary
>market with Microsafe, its revolutionary non-toxic disinfectant
>
> Business Editors
>
> SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 14, 1996--NVID
>International Inc. (OTC BB:NVID) announced Wednesday that in trial
>applications with several veterinarians, NVID's Microsafe F-5 has
>shown to be effective in the treatment of large animals.
> Areas for use will include the following:
> Pre-surgical skin prep
> Trauma wound cleanser and disinfectant
> General anti-microbial wash
> Dermal fungicide treatment
> Anti-Staph infection topical treatment
>
> Microsafe has no odor, does not stain the skin or hair, does not
>produce an "application sting," and is long lasting so fewer
>applications are needed to produce the desired treatment effects
>associated with proper healing.
> Microsafe is non-toxic, safe to handle, easy to administer and
>has shown to produce no adverse side effects in equine, bovine or
>swine applications.
> President Bob Bunte stated: "The initial response from the
>veterinary field has been extremely favorable. With the wide range
>of safe, cost effective applications, we envision use of this product
>in every veterinary office in the country."
> NVID International believes this product should be available for
>general veterinary use before year end.
> NVID International is a developmental holding company. Its
>wholly owned subsidiary is Aqua-Bio Technologies Inc., a development,
>manufacturing, marketing and distribution company for Electronic
>Ionization Water Disinfecting equipment with customers in the
>industrial/commercial, residential and medical markets.
>
> --30--jd/mi*
>
> CONTACT: NVID International Inc., Sarasota
> Robert Bunte, 800/226-3415
> 941/922-2535 (fax)
>
>****************************
>
> SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 20, 1996--NVID
>International Inc. (OTC BB:NVID) announced Tuesday that they have
>successfully completed in house testing using their newest product
>Microsafe F-5 in the veterinary market.
> Several tests were done to show that Microsafe F-5 could
>effectively treat infections on large animals when applied topically.
>The results of these tests were extremely favorable to NVID.
> Microsafe F-5 is one formula of NVID's non-toxic liquid
>disinfectant. Microsafe has no odor, does not stain the skin or
>hair, nor does it produce an "application sting" and is long lasting
>so fewer applications are needed.
> In one clinical test Microsafe F-5 was applied to skin
>irritations on a horse, caused by dew poisoning. Within three days,
>the horse's skin problems began to heal. Prior to the use of
>Microsafe F-5, the horse was treated with the standard fungicides
>and antibiotics, which had little to no effect.
> In another test of a more serious nature, Microsafe F-5 was
>applied to a goat with bacterial infections over its stomach.
>Considerations were made to have this goat destroyed after attempts
>using the standard medications were ineffective. Once again, within
>three days of treatment the wounds of the goat showed considerable
>improvement.
> President Bob Bunte stated: "We are extremely happy with the
> NVID International Inc. believes this product will be available
>for general veterinary use within the next couple of months.
> NVID International is a developmental holding company. Its
>wholly owned subsidiary is Aqua-Bio Technologies Inc., a
>developmental, manufacturing, marketing and distribution company for
>Electronic Ionization Water Disinfecting equipment with customers in
>the industrial/commercial, residential and medical markets.
>
> --30--gaa/mi*
>
> CONTACT: NVID International Inc., Sarasota
> Bob Bunte, 800/226-3415, fax 941/922-2535
>
>*************************
>
>(PR NEWSWIRE) NVID International And EndoDynamics Announce Joint Effort
To R
> NVID International And EndoDynamics Announce Joint Effort To Replace
>Glutaraldehyde With Microsafe
>
> SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 22, 1996--NVID International (OTC
>BB:NVID) and EndoDynamics Thursday announced they are teaming together in a
>joint research effort to replace Glutaraldehyde with MicroSafe for high
level
>disinfection of flexible endoscopes.
> MicroSafe is NVID's new environmentally safe non toxic liquid
disinfectant.
>Flexible G.I. endoscopes are used for non-invasive upper and lower visceral
>examination of the gastro-intestinal tract.
> Currently, Glutaraldehyde is an approved high level disinfectant used for
>cleaning flexible endoscopes in the health care industry, and poses extreme
>environmental and safety hazards for handling, fume recovery and disposal
in
>the hospital setting.
> Glutaraldehyde has shown to act as a contact irritant and allergen on the
>skin and respiratory tract. Inhalation of vapors can cause nose, throat
and
>lung irritation, headaches and nausea. Adequate exhaust ventilation, and
the
>use of protective equipment are required to prevent skin contact and
>inhalation.
> There is currently no suitable substitute for Glutaraldehyde as a
>disinfectant for some medical instruments such as flexible fibre optic
>endoscopes. "Demand for MicroSafe in this type of application could be
>immense," said Marna Schirmer RN and director of Marketing and Sales for
>EndoDynamics.
> The research testing will utilize the current A.S.T.M. Standard protocol
of
>determining the efficacy of disinfection for reusable medical devices
>(Simulated Use Test). The test bacterial that will be used is
Mycobacterium
>terrae, because published information shows that this organism has
comparable
>resistance to antimicrobials, as also displayed by human tuberculosis
strains
>of mycobacterium tuberculosis. NVID's president Robert Bunte stated that,
"If
>tests prove this to be a suitable replacement for Glutaraldehyde, this will
be
>a tremendous relief for this industry by eliminating the current handling
>hazards and further evidence of the wide market potential for our
disinfectant
>products."
> EndoDynamics is a division of Enteric Products Inc. Enteric Products
Inc.
>is a wholly owned subsidiary of E-Z-EM Inc.
> NVID International Inc. is a developmental holding company. It's wholly
>owned subsidiary is Aqua Bio Technologies Inc., a developmental,
>manufacturing, marketing and distribution company for Electronic Water
>Disinfection Equipment with customers in the industrial/commercial,
>residential and medical markets.
>
> CONTACT: NVID International Inc., Sarasota
> Robert Bunte
> 800/226-3415, fax 941/922-2535
>
>
>
>
>
>
>
>
>
BBNS (Bacon Butt News Service) (tm) |
